1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Morten Jorgensen (Inventor), Benny Bang-Andersen (Inventor), Nicholas Moore (Inventor), Andre Faldt (Inventor), Arne Mork (Inventor), Heidi Lopez De Diego (Inventor), Rene Holm (Inventor), Tine Bryan Stensbol (Inventor), Lone Munch Ringgaard (Inventor), Michael J Mealy (Inventor), Michael Harold Rock (Inventor), Jorgen Brodersen (Inventor)

Research output: Patent

Abstract

1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

Original languageEnglish
IPCC07D 295/ 096 A I
Patent numberUS2010297240
Country/TerritoryDenmark
Priority date15/06/2007
Priority numberUS20070301061
Publication statusPublished - 25. Nov 2010
Externally publishedYes

Fingerprint

Dive into the research topics of '1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment'. Together they form a unique fingerprint.

Cite this